Melvyn Rubenfire is a Cardiology physician affiliated with University of Michigan. OpenAlex indexes 381 publications with 10,581 citations (h-index 49); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
24 Frank Lloyd Wright Dr
Ann Arbor, MI 481059484
Telephone
734-998-7400Registry record last updated 4 Apr 2012.
Clinical trials
- Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
94.2%PCSK9 Inhibitor39.1%Repatha Sureclick82%Praluent Pen9%Repatha Syringe9%Part D<11 patientsStatin18.7%Rosuvastatin Calcium80%Atorvastatin Calcium13%Pravastatin Sodium7%Part D<11 patients+ 11 more classes in this area
Blood & clotting
5.8%Factor Xa inhibitor4.8%Eliquis68%Xarelto32%Part D<11 patientsVitamin K antagonist1%Warfarin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1997–2007 per NIH RePORTER. The latest:
- SEARCHING FOR CLUES TO THE PATHOBIOLOGY OF PULMONARY HYPERTENSION
University of Michigan at Ann Arbor
FY2007$22,596M01RR000042 - SEARCHING FOR CLUES TO THE PATHOBIOLOGY OF PULMONARY HYPERTENSION
University of Michigan at Ann Arbor
FY2006$10,220M01RR000042 - LIPID ANALYTES AND ANTHROPOMETRIC MEASUREMENTS IN ETHNIC WOMEN
University of Michigan at Ann Arbor
FY1999M01RR000042
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids
Journal of the American College of Cardiology
2021 - Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations
International Journal of Cardiology
2017 - Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
Current Pharmaceutical Design
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”